Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationThiotepaHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanCombined Modality TherapyGranulocyte Colony-Stimulating FactorLeukapheresisHematologic NeoplasmsAntigens, CD34Antineoplastic Combined Chemotherapy ProtocolsBlood Component RemovalCyclophosphamideStem Cell TransplantationMultiple MyelomaBusulfanMyeloablative AgonistsGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalEtoposideAntineoplastic Agents, AlkylatingHematopoietic Stem CellsRemission InductionRecurrenceCarmustineCytophagocytosisIfosfamideSalvage TherapyVincristineDisease-Free SurvivalAmyloidosisCytarabineHodgkin DiseaseStem CellsHematopoiesisCord Blood Stem Cell TransplantationNeoplasmsSurvival RateTransplantation ChimeraRetrospective StudiesTissue DonorsDoxorubicinSurvival AnalysisWhole-Body IrradiationTime FactorsCarboplatinInfectionLymphoma, T-CellPOEMS SyndromeHistocompatibilityPlatelet CountAntineoplastic AgentsHistocompatibility TestingPrednisoneLeukemia, Myeloid, AcuteImmunosuppressive AgentsDexamethasoneFollow-Up StudiesTransplantation, IsogeneicVidarabineBlood Cell CountRecombinant ProteinsLeukemiaLymphomaProspective StudiesBone Marrow PurgingFeasibility StudiesBlood CellsFatal OutcomeCytomegalovirus InfectionsGraft vs Leukemia EffectTriethylenephosphoramideBreast NeoplasmsMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticPrognosisBlood Transfusion, AutologousLymphocyte DepletionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationBone MarrowHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukocytes, MononuclearT-LymphocytesHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsLivedo ReticularisHLA AntigensCyclosporineBlood DonorsPilot ProjectsMethotrexate